Arvinas, Inc. financial data

Symbol
ARVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
395 Winchester Ave, 5 Science Park, New Haven, Connecticut
State of incorporation
Delaware
Fiscal year end
December 31
Former names
ARVINAS HOLDING COMPANY, LLC (to 9/28/2018)
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 406 % -15%
Debt-to-equity 113 % -5.32%
Return On Equity -64.8 % -27.4%
Return On Assets -30.5 % -31.2%
Operating Margin -557 % -161%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68.4M shares +28.2%
Common Stock, Shares, Outstanding 68.3M shares +27.9%
Entity Public Float 1.29B USD -40.6%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 71.7M shares +34.5%
Weighted Average Number of Shares Outstanding, Diluted 71.7M shares +34.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 71.3M USD -48.1%
Research and Development Expense 369M USD +6.47%
General and Administrative Expense 99.7M USD +18.3%
Operating Income (Loss) -397M USD -35.4%
Nonoperating Income (Expense) 45.1M USD +156%
Income Tax Expense (Benefit) 1.4M USD -91.3%
Net Income (Loss) Attributable to Parent -355M USD -17.9%
Earnings Per Share, Basic -6.05 USD/shares -7.08%
Earnings Per Share, Diluted -6.05 USD/shares -7.08%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 88M USD -32.4%
Marketable Securities, Current 1.08B USD +8.86%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 1.19B USD +3.67%
Property, Plant and Equipment, Net 10.4M USD -22.4%
Operating Lease, Right-of-Use Asset 2M USD -48.7%
Assets 1.21B USD +3.13%
Accounts Payable, Current 17.8M USD +44.7%
Employee-related Liabilities, Current 9.7M USD +34.7%
Accrued Liabilities, Current 30.2M USD +277%
Contract with Customer, Liability, Current 163M USD -24.2%
Liabilities, Current 241M USD -14.9%
Contract with Customer, Liability, Noncurrent 361M USD -4.72%
Operating Lease, Liability, Noncurrent 400K USD -81%
Liabilities 603M USD -9.31%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.4M USD +65.1%
Retained Earnings (Accumulated Deficit) -1.4B USD -33.9%
Stockholders' Equity Attributable to Parent 610M USD +19.3%
Liabilities and Equity 1.21B USD +3.13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -97.5M USD -6.91%
Net Cash Provided by (Used in) Financing Activities 1.6M USD +6.67%
Net Cash Provided by (Used in) Investing Activities -128M USD -192%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 68.3M shares +27.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -224M USD -557%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 93.5M USD -31.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 408M USD +67.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 411M USD +66.4%
Operating Lease, Liability 1.9M USD -52.5%
Depreciation 4.8M USD -23.8%
Payments to Acquire Property, Plant, and Equipment 100K USD -90.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -347M USD -17.6%
Lessee, Operating Lease, Liability, to be Paid 2M USD -52.4%
Property, Plant and Equipment, Gross 32.7M USD +5.48%
Operating Lease, Liability, Current 1.5M USD -21.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 500K USD -77.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 500K USD -77.3%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 100K USD -50%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 65.8M USD +1632%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 900K USD -95.7%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 5.9M USD +43.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Operating Lease, Payments 500K USD 0%
Additional Paid in Capital 2.02B USD +28.3%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 2.6M USD -79.5%
Current Federal Tax Expense (Benefit) -1.7M USD -121%
Share-based Payment Arrangement, Expense 18.6M USD -6.53%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares